Autopsy report · NCT01869738

MGuard™ Prime Stent System Clinical Trial in Patients With Acute ST Elevation Myocardial Infarction

“low enrollment rate”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 2 years 2 months before it stopped.
• 310 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

InspireMD

Sponsor type

Industry

Conditions

ST Elevation Myocardial Infarction

Interventions

MGuard Prime; (BMS/DES)

Participants

310

Sites

56

Countries

Belgium, Czechia, Estonia, Finland, France, Germany, Israel, Netherlands, Poland, Spain, United Kingdom, United States

Trials that died the same way

• Targeted Pharmacological and Behavioral Treatments for Smoking in Schizophrenia Study 1
  “Low rate of enrollment” (97% match in meaning)
• Trial of Supplemental Parenteral Nutrition in Under and Over Weight Critically Ill Patients (TOP-UP)
  “Low enrollment rates.” (91% match in meaning)
• The Use of Proton Pump Inhibitor on the Prevention of Gastric Cancer Bleeding
  “Low enroll rate” (90% match in meaning)
• Lateral Ankle Sprain Study
  “low enrollment” (89% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.